Treating to target in multiple sclerosis: Do we know how to measure whether we hit it?
Sign Up to like & getrecommendations! Published in 2024 at "European Journal of Neurology"
DOI: 10.1111/ene.16526
Abstract: The rapidly evolving landscape of effective treatment options in multiple sclerosis has led to a shift of treatment objectives towards a treat‐to‐target approach aiming to suppress disease activity below the level of detectability early during… read more here.
Keywords: sclerosis know; multiple sclerosis; treating target; target multiple ... See more keywords
Imprinted Genes and Multiple Sclerosis: What Do We Know?
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms22031346
Abstract: Multiple sclerosis (MS) is a chronic autoimmune neurodegenerative disease of the central nervous system that arises from interplay between non-genetic and genetic risk factors. The epigenetics functions as a link between these factors, affecting gene… read more here.
Keywords: imprinted genes; genes multiple; multiple sclerosis; expression ... See more keywords